Abstracts
C. A. Botero, L. Jill Krasner, Helen B. MacNeill, F. Belque, B. Punjabi, A. K. Raghupathy, R. Haug, A. C. Pinchak, Martin Francœur(Hôpital Charles-Le Moyne), Peter H. Gregson, Marc A. St-Amand, Édith Villeneuve, William M. Splinter(University of Ottawa), Josée G. Lavoie, F. Ditzig, S. J. Kleiman, M. Burbridge, Éric Troncy(Université de Montréal), Craig W. Reid, C. E. Smith, Alan H. Menkis, Lawrence Roy, Donna D. Baird(National Institute of Environmental Health Sciences), nR. W. M. Wahba, Michael J. Tessler, William P. S. McKay, Travis Blanchet, Pierre Williot, Irvin Mayers, C. Holbrook, G. Kember, Miklavs Erjavec, Benjamin McKay, Helen Holtby(Hospital for Sick Children), Howard Melnik, Taras Mycyk, Louise Cyrenne, P. T. Cox, David J. Roberts, David H. Johnson(Boston Children's Hospital), Steven G. Parker(University of Utah), Dónal B. Downey, John M. Murkin(University Hospital), Marc Charbonneau, Gilbert Blaise(Sunnybrook Health Science Centre), Patrick Vinay, Elliot J. Rhine, Daniel Vischoff, Fan Yang(Cangzhou Central Hospital), Dorothy Thomson
Cited by 0
Related Papers
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
|Journal of Clinical Oncology|2004|1.7k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2009|913
Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
|Free Radical Biology and Medicine|2004|697